Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KemPharm
Biotech
Orphazyme meme ends with $13M sale to satisfy bankruptcy court
Having briefly commanded a market cap of $2.7 billion in June 2021, the Danish meme stock is selling its assets to KemPharm for $12.8 million in cash.
Nick Paul Taylor
May 16, 2022 6:06am
AI player twoXAR teams with 1ST on glioblastoma
Jan 3, 2019 7:30am
Cash reserves running low at KemPharm
Mar 30, 2018 8:23am
FDA overrides adcomm, shoots down KemPharm’s opioid
Jun 13, 2016 4:35pm
FDA advisers spurn KemPharm’s abuse-deterrent claim for opioid
May 6, 2016 8:20am